Abcellera Biologics
Price & Volume
Stats
See more52W Range | $2.74-$6.86 |
Market Cap | $1.8B |
Shares Short | 47M |
Financials
See moreRevenue (12 Mos) | $79.2M |
Revenue Growth (YoY) | 96.3% |
Gross Profit (12 Mos) | -$111.7M |
Diluted EPS | -$0.48 |
News
See moreYahoo Finance • 7 hours ago
Health Care had the best week vs. the S&P 500 on record
Yahoo Finance • 8 days ago
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
Yahoo Finance • last month
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
Yahoo Finance • 2 months ago
Why AbCellera Biologics (ABCL) Is Up 16.1% After ABCL635 Trial Momentum Builds Ahead Of Data
About
CEO | Dr. Carl L.G. Hansen Ph.D. |
Address | 150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 562 |